U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 4-10, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 4-10, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 07/07/2021
Location: Virtual
Subject: COVID-19 Vaccines and Considerations During Pregnancy
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the American College of Obstetricians and Gynecologists

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/08/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/08/2021
Location: Virtual
Subject: Mutual Recognition Agreement (MRA)
FDA Participant/Group: RAVI BHARWANI; JOSEPH RIERAS; JADE PHAM; KRISTAN CALLAHAN; ELOISA NORIEGA;
Non FDA Participant/Group: Representatives from Norwegian Medicines Agency

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/08/2021
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authority (ICMRA) Workshop; Enabling Manufacturing Capacity in the COVID-19 Pandemic
FDA Participant/Group: THERESA MULLIN; PETER MARKS; PATRIZIA CAVAZZONI;
Non FDA Participant/Group: Lorraine Nolan (Health Products Regulatory Authority (HPRA)); Yasuhiro Fujiwara (Pharmaceuticals and Medical Devices Agency (PMDA)); Emer Cooke (European Medicines Agency (EMA)); June Raine (Medicines and Healthcare Products Regulatory Agency (MHRA));

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top